Nitric oxide synthase (NOS) in schizophrenia

Akbarian S., Bunney W. E., Potkin S. G., Wigal S. B., Hagman J. O., Sandman C. A., and Jones E. G. (1993a) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.Arch. Gen. Psychiatry 50, 169–177.

Akbarian S., Vineula A., Kim J. J., Potkin S. G., Bunney W. E., and Jones E. G. (1993b) Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development.Arch. Gen. Psychiatry 50, 178–187.

Dawson T. M. and Dawson V. L. (1995) Nitric oxide: action and pathological roles.The Neuroscientist 1, 7–18.

Dawson T. M., Snyder S. H. (1994) Gases as biological messengers: Nitric oxide and carbon monoxide in the brain.J. Neurosci. 14, 5147–5159.

Dawson T. M., Bredt D. S., Fotuhi M., Hwang P. M., and Snyder S. (1991) Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues.Proc. Natl. Acad. Sci. USA 88, 7797–7801.

Dinerman J. L., Dawson T. M., Schell M. U. J., Snowman A., Snyder S. H. (1994) Enolase nitrox oxide synthase localized to hippocampal pyramidal cells. Implications for synaptic plasticity.Proc. Natl. Acad. Sci. USA 91, 4214–4218.

Garcia-Rill E., Davies D. L., and Skinner R. D. (1991) Fibroblast growth factor-induced increased survival of cholinergic mesopontine neurons in culture.Dev. Brain Res. 60, 267–270.

Garcia-Rill E., Karson C. N., Husain M. M., Biederman J. A., Chambers T., and Skinner R. D. (1995) Mesopontine neurons in schizophrenia.J. Neurosci. 66, 321–335.

Heath R. G., Franklin D. E., Walker C. F., and Keating J. W. (1982) Cerebellar vermal atrophy in psychiatric patients.Biol. Psychiatry 17, 569–583.

Hope B. T., Michael G. J., Knigge K. M., and Vincent R. S. (1991) Neuronal NADPH diaphorase is a nitric oxide synthase.Proc. Natl. Acad. Sci. USA 88, 2811–2814.

Hu J., Lee J. H., and El-Fakahany E. E. (1993) Inhibition of neuronal nitric oxide synthase by antipsychotic drugs.Neurosci. Res. Psychiatry 3, 161–166.

Karson C. N., Dykman R. A., and Paige S. R. (1990) Blink rates in schizophrenia.Schizophr. Bull. 2, 16, 345–354.

Karson C. N., Garcia-Rill E., Biedermann J., Mrak R. E., Husain M. M., and Skinner R. D. (1991) The brainstem reticular formation in schizophrenia.Psychiatry Res. Neuroimaging 40, 31–48.

Karson C. N., Garcia-Rill E., Biedermann J. (1991) The brainstem reticular formation in schizophrenia.Psychiatry Res. 40, 31–48.

Karson C. N., Casanova M. F., Kleinman J. E., Griffin W. S. T. (1993) Choline acetyltransferase in schizophrenia.Am. J. Psychiatry 150, 3, 454–459.

Knusel B. and Hefti F. (1988) Development of cholinergic pedunculopontine neurons in vitro: Comparison with cholinergic septal cells and response to nerve growth factor, ciliary neuronotrophic factor, and retinoic acid.J. Neurosci. Res. 21, 365–375.

Lipton S. A., Chol Y.-B., and Pan Z-H. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitrous-compounds.Nature 364, 626–632.

Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., VanBelle G., Berg L., and participating CERAD Neuropathologists (1991) The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease.Neurology 41, 479–486.

Salzman S., Endicott J., and Clayton P. (eds) (1983). Diagnostic Evaluation After Death (DEAD). National Institutes of Mental Health (NIMH) Neuroscience Research Branch, Rockville, MD.

Siegel S. (1956) Nonparametric statistics for the behavioral sciences, inMcGraw-Hill Series in Psychology (Harlow H. F., ed.), McGraw-Hill, New York, pp. 116–127.

Weinberger D. R., Kleinman J. E., Luchins D. J., Bigelow L. B., and Wyatt R. F. (1980) Cerebellar pathology in schizophrenia: A controlled postmortem study.Am. J. Psychiatry 137, 3, 359–361.